Kerala SMA Drug Distribution Controversy

What this timeline covers

This event covers the opposition by parents of children with Spinal Muscular Atrophy to the Keralam government's plan to replace Roche Pharma's Risdiplam with a Natco generic, including its reactions, analyses, and follow-up developments. It excludes other actions by the parents, the Keralam government, or the Cure SMA Foundation of India unless they are developments of this specific occurrence.